Retinoblastoma 2022
O retinoblastoma é um tumor maligno ocular com mais frequência na infância e pode causar cegueira e morte.
possui uma incidência de um a cada 15 ou 30.000 nascidos
– O retinoblastoma possui uma incidência de um a cada 15 ou 30.000 nascidos vivos, aproximadamente 3% em crianças menores de dois anos de idade e 5% em crianças maiores de cinco anos de idade.
– Cerca de 25% apresentam tumor bilateral (hereditário); outros 15% em processo unilateral e hereditário; e 60% com doença unilateral e não hereditária.
■ Recent advancements in the management of retinoblastoma and uveal melanoma
Amy C Schefler, Ryan S Kim
Fac Rev. 2021; 10: 51.
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8204763/
■ Changes in treatment patterns and globe salvage rate of advanced retinoblastoma in Korea: efficacy of intra-arterial chemotherapy
Dong Hyun Lee, Jung Woo Han, Seung Min Hahn et al
J Clin Med. 2021 Nov; 10(22): 5421
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8619482/
■ At what age could screening for familial retinoblastoma be discontined? A systematic review
Milo van Hoefen Wijsard, Saskia H. Serné, René H. Otten et al
Cancers (Basel) 2021 Apr; 13(8): 1942
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8072927/
■ Current indications of secondary enucleation in retinoblastoma management: a pósiton paper on Behalf of the European Retinoblastoma Group
Christina Stathopoulos, Livia Lumbroso-Le Rouic, Annette C. Moll et al
Cancers (Basel) 2021 Jul; 13(14): 3392
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8303810/
■ Introduction of a variant classification system for analysis of genotype-phenotype relationship in heritable retinoblastoma
Isabel Hülsenbeck, Mirjam Frank, Eva Biewald,et al
Cancers (Basel) 2021 Apr; 13(7): 1605
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8037437/
■ Whole-genome sequencing of retinoblastoma reveals the diversity of rearrangements disrupting RB1 and uncovers a treatment-related mutational signatures
Helen R. Davies, Kevin D. Broad, Zerrin Onadim et al
Cancers (Basel) 2021 Feb; 13(4): 754
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7918943/
■ Qumioterapia intrarterial para el manejo del retinoblastoma
J C Gómez-Veja, M I Ocampo-Navia, J José Botero-Trujillo et al
Univ Med 2021, vol 62 (4)
■ Retrato de familiares acompanhantes de crianças e adolescentes atendidos por retinoblastoma no Brasil: Estudo transversal
M I P Messias, G S Bochi, A N F da Silva et al
Research, Society & Development 2021, vol 10 (5)
https://rsdjournal.org/index.php/rsd/article/view/15096/13503
■ Long-term of subsequente cancer incidence among hereditary and nonhereditary retinoblastoma survivors
Sara J. Schonfeld, Ruth A. Kleinerman, David H. Abramson et al
Br J Cancer. 2021 Mar 30; 124(7): 1312–1319
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8007574/
■ Benign tumors in long-term survivors of retinoblastoma
Milo van Hoefen Wijsard, Sara J. Schonfeld, Flora E. van Leeuwen et al
Cancers (Basel) 2021 Apr; 13(8): 1773
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8068196/
■ Subsequent malignant neoplasms in retinoblastoma survivors
Armida W. M. Fabius, Milo van Hoefen Wijsard, Flora E. van Leeuwen, Annette C. Moll
Cancers (Basel) 2021 Mar; 13(6): 1200
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8001190/
■ Parenteral occupation and risk of chilhood retinoblastoma in Denmark
Negar Omidakhsh, Johnni Hansen, Beate Ritz, et al
J Occup Environ Med. 2021 Mar 1; 63(3): 256–261
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8259454/
■ The impact of cell-free DNA analysis on the management of retinoblastoma
Amy Gerrish, Helen Jenkinson, Trevor Cole
Cancers (Basel) 2021 Apr; 13(7): 157
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8037190/
■ Multi-functionalized nanomaterials and nanoparticles for diagnosis and treatment of retinoblastoma
Rabia Arshad, Mahmood Barani, Abbas Rahdar,et al
Biosensors (Basel) 2021 Apr; 11(4): 9
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8066896/
■ A hign-risk retinoblastoma subtype with stmnes features, dedifferentiated cone states and neuronal/ganglion cell gene expression.
Jing Liu, Daniela Ottaviani, Meriem Sefta et al
Nat Commun. 2021; 12: 5578
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8458383/
■ Response criteria for intraocular retinoblastoma: RB-RECIST
Jesse L. Berry, Francis L. Munier, Brenda L. Gallie et al
Pediatr Blood Cancer. 2021 May; 68(5): e28964
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8049511/
■ Retinoblastoma from human stem cell-derived retinal organoids
Jackie L. Norrie, Anjana Nityanandam, Karen Lai, et al
Nat Commun. 2021; 12: 4535
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC8316454/
■ A single arm study of systemic and sub-Tenon chemotherapy for groups C and D intraocular retinoblastoma, a Children´s Oncology Group Study (ARET 0231)
Rima F. Jubran, Judith G. Villablanca, Mark Krailo et al
Pediatr Blood Cancer. 2020 Sep; 67(9): e28502
https://www.ncbi.nlm.nih.gov/labs/pmc/articles/PMC7857974/
■ Dr Paulo Fernando Leite
Cardiologia/Prevenção Cardiovascular
Consultório: Rua Padre Rolim 815/sala 601 – Belo Horizonte/MG/Brasil
Tel: 33245518
CRMMG: 7026
Email: pfleite1873@gmail.com
Blog Internet Médica – www.internetmedica.com.br
Data: janeiro 2022